BIOLOGICALLY ACTIVE SUPPLEMENTS AS A PERSPECTIVE DIRECTION OF DEVELOPMENT OF THE PHARMACEUTICAL MARKET
The article presents the results of a marketing research of assortment of biologically active supplements (BAS) on the Russian market. It also provides a classification and characterization of the BAS. BAS is a concentrate of natural or identical to natural biologically active substances intended for direct reception or introduction into the food composition in order to enrich the diet with biologically active substances or their complexes. Biologically active food supplements are usually obtained from plant, animal or mineral raw materials as well as chemical or biotechnological methods (the Ministry of Health order № 117 dated 15.04.1997) “On the procedure of examination and hygienic certification of biologically active food supplements"). Dietary supplements have an important advantage over drugs: the latter can sometimes cause changes that are not characteristic of a healthy body, and supplements regulate the body within normal limits, as they are natural or identical to natural substances. Dietary supplements are gaining prevalence in the diet of different population groups. What is more, the phenomenon can be observed both in Russia and in other economically developed countries. One of the main causes of use of dietary supplements is significant violations of the quality and structure of the modern human nutrition. Dietary supplements quickly fill the Russian pharmaceutical market, occupying the second place after pharmaceuticals. In addition, about 20% of manufacturers of dietary supplements are manufacturers of drugs. Thus, the article found confirmation of the belief that dietary supplements can extend the range of pharmacy, thereby increasing the satisfaction of visitors of pharmacies, improving the quality of pharmaceutical care of the population.
Ivashenkova A, Belousova OV, Belousov EA. Biologically active supplements as a perspective direction of development of the pharmaceutical market. Research Result. Medicine and Pharmacy. 2016;2(4):89-94 (In Russian). DOI: 10.18413/2313-8955-2016-2-4-89-94
While nobody left any comments to this publication.
You can be first.
1. Belousov E.A., Belousova, O. V., Trofimova V. G. Study of Demand for Drugs for the Treatment of Skin Diseases. Research Result. Series "Medicine and Pharmacy" 2016. Vol. 2, N. 1(7). Pp. 59-63.
2. Belousov E.A., Belousova O.V. The Impact of Marketing Approaches on a Complex Sale in the Drugstore. Research Result. Series "Medicine and Pharmacy" 2015. №3(5). Pp. 139-142.
3. Belousova O.V., Belousov E.A., Lupandina L.O. Analysis of the Range of Homeopathic Medicines on the Russian Pharmaceutical and Pharmacy Markets. Research Result. Series "Medicine and Pharmacy". 2016. Vol. 2, N. 2. Pp. 50-53.
4. Grigoriev D. Analysis of the Market of Biologically Active Suplements. Business medicine. 2005. N.8. Pp.78-82.
5. Kurbanova M.G. Study and Development of Multifunctional Additives Based on Hydrolysates of Casein and the Practical Implementation of Technologies for Food Products using them: dis. ... d-RA tekhn. Sciences: 05.18.04 Kurbanova Marina Gennadievna. Kemerovo, 2012. 369 p.
6. MUK 2.3.2.721-98. 2.3.2. Food Products and Food Additives. Determination of the Safety and Efficacy of Biologically Active Supplements to Food. Guidelines (approved. Chief state sanitary doctor of Russia 15.10.1998)
7. About the Procedure of Examination and Hygienic Certification of Biologically Active Food Additives: the Order of the Ministry of Health of the Russian Federation of N 117 15.04.1997 URL: http://www.consultant.ru/document/cons_doc_LAW_14778/14194834fc3db4dcc7bcf423edd16b76f271500c/ (date of access: August 10, 2016)
8. Poznyakovsky V.M., Sukhanov B.P. Biologically Active Substances in the Modern Nutrition. Equipment and Technology of Food Production. 2009. N.2. Pp. 44-50.
9. Simakova S.A., Iskhakova G.M., Purygin P.P. Application of a Composition of Potassium Humate and Spirulina as a Biologically Active Food Supplement. Proceedings of the Samara Scientific Center of RAS. 2009. Vol. 11 (27), № 1 (5). Pp. 1097-1099.
10. Danzon P.M., Chao L-W. Cross-national price differences for pharmaceuticals: how large, and why? Journal of health economics. 2000. 19. Pp. 159-195.
11. Danzon P.M. Making Sense of drug prices. Regulation. 2000. 23, l. Pp. 56-63.
12. Kelly G.G. Improving the PPI sample for prescription pharmaceuticals. -USA: Bureau of Labor Statistics, 1999. 26p.
13. Koletzko В. Agget P.J., Bindels J.G. et al. Growth, Development and Differentiation: a functional food science approach. British J. Nutrition. 1998. Vol. 80. Suppl. 1. Pp. 5-45.
14. Sweeny K. Demand and price dynamics within the pharmaceutical benefits scheme. Melbourne, Australia: Center for Strategic Economic Studies Victoria University of Technology, 2002. 47 p